Close Menu

NEW YORK – Akadeum Life Sciences announced on Thursday an initial close of its Series A financing, which will be used to "solve longstanding problems in sample preparation."

A spokesman for the Ann Arbor, Michigan-based firm said that it has raised about $4 million in the Series A round so far but declined to say how much it plans to raise in total "because we expect the round to be oversubscribed." In a statement, Akadeum added that it is pursuing additional financing during the first quarter of 2020 when the Series A round is anticipated to close.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.